Clinical trial
BreathID Multi-center HCV Liver Breath Test Study
NCT00350714 · Meridian Bioscience, Inc., Industry · Terminated
Key facts
| NCT number | NCT00350714 |
|---|---|
| Title | BreathID Multi-center HCV Liver Breath Test Study |
| Official title | Validation of a Breath Test for Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C Viral Infection |
| Lead sponsor | Meridian Bioscience, Inc., Industry |
| Collaborators | Icahn School of Medicine at Mount Sinai Baylor College of Medicine Virginia Commonwealth University Hadassah Medical Organization US Department of Veterans Affairs U.S. Fed |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Other |
| Interventions | MBT and BreathID |
| Enrollment | 75 |
| Start date | Jul 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jul 11, 2006 |
| Last update posted | Dec 20, 2022 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: